Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Gynecology · Premenstrual Dysphoric Disorder

Building Your Care Team and Preparing for Your Visit

At a Glance

To prepare for PMDD care, track symptoms every day for at least two months—including days you feel well—mark period starts, record effects on daily life and treatment history, and share the information with a clinician who can coordinate care; urgent safety concerns should never wait.

Building a care team for Premenstrual Dysphoric Disorder (PMDD) can be a challenging journey, often described by patients as a “diagnostic odyssey” [1][2]. Because PMDD sits at the intersection of endocrinology, gynecology, and psychiatry, you may need a collaborative approach to ensure all aspects of the condition are addressed [3][4].

Your Core Care Team

A well-rounded care team often involves several specialists working together. While a multidisciplinary team is highly effective, remember that PMDD can also often be assessed and initially treated by your primary care provider or general gynecologist:

  • Gynecologist or Primary Care Provider (PCP): They often lead the initial assessment, order individualized testing (such as checking for thyroid issues, anemia, or sleep disorders), rule out pelvic conditions like endometriosis, and manage initial hormonal treatments [5][6].
  • Reproductive Psychiatrist: This is a psychiatrist with specialized training in how hormones affect mood. They are uniquely qualified to distinguish PMDD from other mood disorders and manage cycle-specific medication, though a general psychiatrist is also a strong option if one is not locally available [3][7].
  • Clinical Psychologist: Cognitive Behavioral Therapy (CBT) has been shown to reduce the functional and psychological burden of PMDD [8][4].

The Essential “Artifacts” for Your Visit

The most important thing you can bring to your appointment is data. Because retrospective memory (looking back) is often unreliable, prospective (real-time) tracking is strongly recommended by clinical guidelines [9][10]. However, please note that a clinician can make a provisional diagnosis, start safety planning, and begin reasonable treatment while you continue gathering this data—you do not have to delay urgent care.

  1. Two Months of Daily Logs: Bringing at least two consecutive months of daily symptom ratings is incredibly helpful [11][9]. Use a validated tool like the Daily Record of Severity of Problems (DRSP) or the C-PASS [10].
  2. Mark Your “Day 1”: Clearly indicate the first day of your period (or withdrawal bleeding if on contraceptives) for each cycle. This allows the doctor to see the “on/off” switch that defines PMDD [12][13].
  3. Functional Impairment Data: Don’t just track mood; track how symptoms affect your ability to work, attend school, maintain relationships, or handle self-care [14][15].
  4. Treatment History: Bring a list of every medication, birth control, or supplement you have tried, including the dates, doses, and how they affected your symptoms [16][6]. Also bring any records regarding pregnancy plans or major medication changes.

Vetting Your Provider

To ensure you are receiving evidence-based care, you can ask questions to gauge your provider’s experience and approach [5][17]:

  • Ask about tracking: Discuss how they use daily logs. A knowledgeable provider will appreciate prospective data rather than relying solely on memory or screening tools [9][5].
  • Ask about PME: Ask how they distinguish PMDD from Premenstrual Exacerbation (PME)—the worsening of an underlying condition like depression or anxiety [18][19]. A knowledgeable provider will know that PMDD involves symptoms becoming minimal in the postmenstrual week [9][20].
  • Suicidality Assessment: Because PMDD carries a high risk of suicidal ideation, a competent provider should explicitly ask about your safety during the luteal phase and help you formulate a crisis plan [21][22].

Advocating for Collaborative Care

If a provider dismisses or minimizes your symptoms as just typical hormonal changes, it is a sign that they may not be the right fit for this condition [1][23].

In these moments, you can advocate for yourself by stating: “I have prospective daily tracking showing a clear luteal-phase shift and functional impairment. Can we review this data together?” If they decline, or if you feel your safety concerns are not being addressed, it is entirely appropriate to seek a second opinion or a specialist referral [2][5]. You are the expert on your own body and your own data, and you deserve a collaborative care team [1].

Common questions in this guide

What kind of doctor should I see for PMDD?
A primary care provider or gynecologist can often begin the assessment and initial treatment for PMDD. A psychiatrist with expertise in menstrual-related mood symptoms and a psychologist who provides cognitive behavioral therapy may be added when symptoms are severe, complex, or difficult to treat.
How long should I track symptoms before a PMDD appointment?
Track symptoms every day for at least two consecutive months, including days when you feel well. Mark the first day of each period, or withdrawal bleeding if you use hormonal contraception, and note how symptoms affect work, school, relationships, and self-care. Daily tools such as DRSP or C-PASS can help.
What should I bring to a PMDD appointment?
Bring your daily symptom logs, the dates your periods begin, and notes about effects on work, school, relationships, and self-care. Also list every medication, contraceptive, and supplement you have tried, with dates, doses, effects, and any pregnancy plans or major medication changes.
How is PMDD different from premenstrual exacerbation?
PMDD symptoms are mainly present before menstruation and become minimal after the period begins. Premenstrual exacerbation means an existing condition, such as depression or anxiety, worsens before the period but continues at other times. Daily tracking helps a clinician compare these patterns.
What can I do if a PMDD provider dismisses my symptoms?
Share your daily records and explain the effect on your functioning and safety. If a clinician minimizes your symptoms or does not address safety concerns, you can request a second opinion or referral to a specialist. If you may harm yourself or are in immediate danger, contact local emergency services or a crisis service and stay with a trusted person.
Do I need to wait two months of tracking before getting PMDD care?
No. Daily tracking strengthens the evaluation, but you do not have to wait two months for a clinician to make a provisional assessment, create a safety plan, or begin reasonable treatment when needed. Urgent safety concerns should be addressed immediately.

Get notified when new evidence is published on premenstrual tension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (23)
  1. 1

    Medical gas-lighting, diagnostic odyssey and self-advocacy among women with premenstrual dysphoric disorder from nine countries.

    Mosalisa M, Roomaney R

    Journal of health psychology 2026; (31(8)):3227-3240 doi:10.1177/13591053251401286.

    PMID: 41540801
  2. 2

    Barriers to Diagnosis and Treatment for Premenstrual Dysphoric Disorder (PMDD): A Scoping Review.

    Nayak A, Wood SN, Hantsoo L

    Reproductive sciences (Thousand Oaks, Calif.) 2025; (32(6)):1757-1767 doi:10.1007/s43032-025-01861-3.

    PMID: 40251463
  3. 3

    Premenstrual disorders and PMDD - a review.

    Cary E, Simpson P

    Best practice & research. Clinical endocrinology & metabolism 2024; (38(1)):101858 doi:10.1016/j.beem.2023.101858.

    PMID: 38182436
  4. 4

    Management of Premenstrual Disorders: ACOG Clinical Practice Guideline No. 7.

    Obstetrics and gynecology 2023; (142(6)):1516-1533 doi:10.1097/AOG.0000000000005426.

    PMID: 37973069
  5. 5

    Patient Experiences of Health Care Providers in Premenstrual Dysphoric Disorder: Examining the Role of Provider Specialty.

    Hantsoo L, Sajid H, Murphy L, et al.

    Journal of women's health (2002) 2022; (31(1)):100-109 doi:10.1089/jwh.2020.8797.

    PMID: 33978482
  6. 6

    Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives.

    Rapkin AJ, Korotkaya Y, Taylor KC

    Open access journal of contraception 2019; (10()):27-39 doi:10.2147/OAJC.S183193.

    PMID: 31572029
  7. 7

    Trajectories and dimensional phenotypes of depressive symptoms throughout pregnancy and postpartum in relation to prior premenstrual symptoms.

    Schleimann-Jensen E, Sundström-Poromaa I, Meltzer-Brody S, et al.

    The British journal of psychiatry : the journal of mental science 2025; (226(6)):401-409 doi:10.1192/bjp.2025.38.

    PMID: 40538355
  8. 8

    Internet-Based Cognitive-Behavioural Intervention for Women with Premenstrual Dysphoric Disorder: A Randomized Controlled Trial.

    Weise C, Kaiser G, Janda C, et al.

    Psychotherapy and psychosomatics 2019; (88(1)):16-29 doi:10.1159/000496237.

    PMID: 30783069
  9. 9

    Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).

    Eisenlohr-Moul TA, Girdler SS, Schmalenberger KM, et al.

    The American journal of psychiatry 2017; (174(1)):51-59 doi:10.1176/appi.ajp.2016.15121510.

    PMID: 27523500
  10. 10

    Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST).

    Henz A, Ferreira CF, Oderich CL, et al.

    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2018; (40(1)):20-25 doi:10.1055/s-0037-1608672.

    PMID: 29132173
  11. 11

    The pharmacotherapeutic management of premenstrual dysphoric disorder.

    Ciccone N, Kovacheff MB, Frey BN

    Expert opinion on pharmacotherapy 2023; (24(1)):145-151 doi:10.1080/14656566.2022.2114345.

    PMID: 35974667
  12. 12

    The reliability and validity of the Japanese version of the Daily Record of Severity of Problems (J-DRSP) and Development of a Short-Form version (J-DRSP (SF)) to assess symptoms of premenstrual syndrome among Japanese women.

    Ikeda Y, Egawa M, Okamoto K, et al.

    BioPsychoSocial medicine 2021; (15(1)):6 doi:10.1186/s13030-021-00208-z.

    PMID: 33736660
  13. 13

    Gold-standard evidence and best practice guidance for menstrual cycle-informed clinical care: An overview for clinicians.

    Lambert ER, Nolan LN, Schmalenberger KM

    The British journal of clinical psychology 2026; doi:10.1111/bjc.70066.

    PMID: 42162940
  14. 14

    Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial.

    Yonkers KA, Altemus M, Gilstad-Hayden K, et al.

    Journal of clinical psychopharmacology 2023; (43(4)):320-325 doi:10.1097/JCP.0000000000001700.

    PMID: 37212651
  15. 15

    Daily symptom ratings for studying premenstrual dysphoric disorder: A review.

    Bosman RC, Jung SE, Miloserdov K, et al.

    Journal of affective disorders 2016; (189()):43-53.

    PMID: 26406968
  16. 16

    Premenstrual syndrome and premenstrual dysphoric disorder

    Kovács Z, Hegyi G, Szőke H

    Orvosi hetilap 2022; (163(26)):1023-1031 doi:10.1556/650.2022.32496.

    PMID: 35895486
  17. 17

    Patient Perspectives of Healthcare for Premenstrual Dysphoric Disorder in Australia: A Mixed-Methods Study.

    Border G, Miller YD

    Health services insights 2026; (19()):11786329251409981 doi:10.1177/11786329251409981.

    PMID: 41523196
  18. 18

    Premenstrual exacerbation of psychiatric symptoms: from misdiagnosis to management.

    Kulkarni J, Mu E

    The British journal of psychiatry : the journal of mental science 2025; (226(6)):346-348 doi:10.1192/bjp.2024.295.

    PMID: 40468821
  19. 19

    Premenstrual dysphoric disorder and associated factors among female health science students in Wollo University, Ethiopia, 2017/18.

    Tsegaye D, Getachew Y

    Maternal health, neonatology and perinatology 2019; (5()):8 doi:10.1186/s40748-019-0102-z.

    PMID: 31139430
  20. 20

    Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study.

    Yen JY, Lin PC, Huang MF, et al.

    International journal of environmental research and public health 2020; (17(3)) doi:10.3390/ijerph17030988.

    PMID: 32033286
  21. 21

    Suicidal Risk in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Systematic Review and Meta-Analysis.

    Prasad D, Wollenhaupt-Aguiar B, Kidd KN, et al.

    Journal of women's health (2002) 2021; (30(12)):1693-1707 doi:10.1089/jwh.2021.0185.

    PMID: 34415776
  22. 22

    Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder.

    Wikman A, Sacher J, Bixo M, et al.

    BMC women's health 2022; (22(1)):35 doi:10.1186/s12905-022-01612-5.

    PMID: 35148753
  23. 23

    The experiences and psychological impact of living with premenstrual disorders: a systematic review and thematic synthesis.

    Brown D, Smith DM, Osborn E, Wittkowski A

    Frontiers in psychiatry 2024; (15()):1440690 doi:10.3389/fpsyt.2024.1440690.

    PMID: 39286397

This page is for informational purposes only and does not constitute medical advice about PMDD. Your healthcare team should interpret your symptom records and address any urgent safety concerns.

Guide contents premenstrual tension
Research & Literature
05 Advanced Care